Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) Short Interest Update

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totaling 45,023 shares, an increase of 38.3% from the November 30th total of 32,560 shares. Based on an average trading volume of 30,871 shares, the days-to-cover ratio is currently 1.5 days. Based on an average trading volume of 30,871 shares, the days-to-cover ratio is currently 1.5 days.

Medexus Pharmaceuticals Trading Up 0.2%

Shares of Medexus Pharmaceuticals stock traded up $0.00 during mid-day trading on Tuesday, reaching $2.13. 21,368 shares of the stock were exchanged, compared to its average volume of 18,681. Medexus Pharmaceuticals has a fifty-two week low of $1.43 and a fifty-two week high of $3.88. The firm has a 50-day simple moving average of $1.94 and a 200 day simple moving average of $2.06.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.